Wow - a must read! Excerpt: Then there’s Samsung’s biopharmaceutical arm, Samsung Biologics. In the first quarter of this year, ending in March, sales for Samsung Electronics rose 5.6 percent year over year, while sales for Samsung Biologics jumped 65.3 percent. The company also ranked first in March for brand reputation among Korean pharmaceuticals. Last month, it clinched a $362 million deal to make coronavirus antibodies for a U.S. start-up and signed a collaboration deal with Asia’s largest pharmaceutical company, Takeda.

Also last month, a Canadian biotech firm reported promising results in treating coronavirus patients with its HIV drug leronlimab, which Samsung Biologics will supply for up to $1 billion over the next few years.

https://foreignpolicy.com/2020/05/13/south-ko...te-reform/